Carbonic anhydrase inhibitors as novel antibacterials in the era of antibiotic resistance: where are we now?

HIGHLIGHTS

• who: Alessio Nocentini et al. from the NEUROFARBA Department, Section of Pharmaceutical and Nutraceutical Sciences, University of Florence have published the paper: Carbonic Anhydrase Inhibitors as Novel Antibacterials in the Era of Antibiotic Resistance: Where Are We Now?, in the Journal: Antibiotics 2023, 142 of /2023/
• what: The well-known zinc-binding groups (ZBGs), such as the primary sulfonamide (-SO2NH2), primary sulfamate (-OSO2 NH2 ), and sulfamide (-NHSO2 NH2 ), which are present in the structure of several clinically-approved drugs and an increasing number of investigational medicines, have been proven to affect the inhibition of the . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.